Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The pharmaceutical industry relies heavily on the availability of high-quality pharmaceutical intermediates to synthesize novel drug candidates and existing therapeutics efficiently. NINGBO INNO PHARMCHEM CO.,LTD. is a key supplier in this sector, providing essential chemical building blocks that facilitate drug development. Pyridine-2,6-dicarboximidamide Dihydrochloride, with its intriguing chemical structure and identified biological activities, presents significant potential as a pharmaceutical intermediate.
The compound's structural features, including the pyridine ring and carboximidamide functionalities, are common motifs found in many biologically active molecules. This inherent structural similarity makes it a promising starting point for the synthesis of a wide range of potential drug candidates. Its role as a chemical synthesis building block allows chemists to introduce specific functionalities and build complex molecular architectures relevant to therapeutic targets.
Notably, research has indicated that derivatives of Pyridine-2,6-dicarboximidamide Dihydrochloride exhibit promising biological activities, including antimicrobial and anticancer properties. These findings are of immense interest to NINGBO INNO PHARMCHEM CO.,LTD. as they suggest the compound's direct relevance in the development of new treatments for infectious diseases and cancer. The ability to act as an enzyme inhibitor further broadens its therapeutic potential, opening avenues for targeted drug design.
The compound's utility extends to its application as a pyridine-2,6-dicarboximidamide dihydrochloride ligand in catalytic processes. Efficient and selective synthesis is a cornerstone of pharmaceutical manufacturing. By employing catalysts that utilize this ligand, NINGBO INNO PHARMCHEM CO.,LTD. can develop streamlined and cost-effective routes for producing complex active pharmaceutical ingredients (APIs). This not only reduces manufacturing complexity but also enhances the sustainability of drug production.
Furthermore, the compound's role in advanced synthetic methodologies, such as reductive cross-electrophile coupling, allows for the precise modification and elaboration of molecular structures. This is critical in the lead optimization phase of drug discovery, where subtle structural changes can dramatically impact a compound's efficacy and safety profile. NINGBO INNO PHARMCHEM CO.,LTD. is committed to supporting the pharmaceutical industry by providing reliable access to such versatile pharmaceutical intermediates, thereby accelerating the journey from laboratory discovery to patient benefit.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
